IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,045,517 | +29.5% | 600,300 | -36.0% | 0.06% | +31.1% |
| Q2 2023 | $17,791,963 | +36.5% | 937,900 | +11.6% | 0.04% | +32.4% |
| Q1 2023 | $13,029,951 | +92.7% | 840,100 | +120.6% | 0.03% | +78.9% |
| Q4 2022 | $6,760,975 | +255.1% | 380,900 | +11.6% | 0.02% | +216.7% |
| Q3 2022 | $1,904,000 | -9.7% | 341,300 | -36.8% | 0.01% | 0.0% |
| Q2 2022 | $2,108,000 | -46.2% | 540,400 | -24.0% | 0.01% | -40.0% |
| Q1 2022 | $3,918,000 | -37.2% | 711,000 | -2.9% | 0.01% | -37.5% |
| Q4 2021 | $6,239,000 | -28.8% | 732,300 | -27.4% | 0.02% | -30.4% |
| Q3 2021 | $8,764,000 | +0.6% | 1,008,500 | +22.4% | 0.02% | 0.0% |
| Q2 2021 | $8,710,000 | -6.5% | 824,000 | +41.9% | 0.02% | -11.5% |
| Q1 2021 | $9,311,000 | +4486.7% | 580,500 | +13093.2% | 0.03% | +2500.0% |
| Q4 2020 | $203,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |